Status:
COMPLETED
Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
SARS-CoV2
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to define seroprevalence of anti-SARS-CoV2 among children of Hospital Workers in APHP, particularly exposed population, according to parents' SARS-CoV2 serological status.
Eligibility Criteria
Inclusion
- Hospital workers :
- Individuals aged over 18, having a professional activity at the APHP (employees, interns, volunteers)
- Affiliated to a social security regimen
- Have at least one child under the age of 18 living in the same house.
- have signed consent
- Child (ren), spouse and other member (s) residing at household:
- Child (ren), spouse and any other member residing in the household of a professional of the Paris Center Hospitals meeting the inclusion criteria above.
Exclusion
- Refuse to participate in research
Key Trial Info
Start Date :
June 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
563 Patients enrolled
Trial Details
Trial ID
NCT04442087
Start Date
June 19 2020
End Date
April 30 2021
Last Update
November 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital
Paris, France, 75015